JP Morgan Chase
LUNG icon

JP Morgan Chase’s Pulmonx LUNG Stock Holding History

JP Morgan Chase’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-99,300
Closed -$2.46M – 6699
2022
Q1 		$2.46M Buy
+99,300
New +$2.56M ﹤0.01% 3598

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase's LUNG Position: Q1 2026 in Review

JP Morgan Chase reduced its Pulmonx (LUNG) stake by 9.1% in Q1 2026, selling an estimated $63.9K and leaving 388,103 shares worth $458K. The position accounts for ﹤0.01% of the portfolio, ranked #5086.

JP Morgan Chase first reported a position in LUNG in Q4 2020 and has held it in 22 quarters since. The position peaked at $8.75M in Q3 2024. 114 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

  • JP Morgan Chase held 388,103 shares of Pulmonx worth $458K as of Q1 2026.
  • JP Morgan Chase sold 38,676 Pulmonx shares in Q1 2026, an estimated $63.9K.
  • Pulmonx made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5086 holding.
  • JP Morgan Chase first reported a position in Pulmonx in Q4 2020 and has held it in 22 quarters since.
  • JP Morgan Chase's Pulmonx position peaked at $8.75M in Q3 2024.
  • 114 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.